Insider Transactions in Q3 2022 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,536
-43.34%
|
$2,536
$1.97 P/Share
|
|
Aug 01
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
2,983
-38.18%
|
$2,983
$1.77 P/Share
|
|
Aug 01
2022
|
Cintia Piccina Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
21,040
-37.66%
|
$21,040
$1.77 P/Share
|
|
Jul 05
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
1,973
-38.86%
|
$1,973
$1.68 P/Share
|